PREPARATION, CHARACTERIZATION AND SAFETY ASSESSMENT OF COMBINATORIAL NANOPARTICLES OF CARVEDILOL AND SERICIN
DOI:
https://doi.org/10.22159/ijap.2022v14i3.44357Keywords:
Nanoparticle, Carvedilol, Sericin, OECD, ToxicityAbstract
Objective: The objective of the study is to prepare and evaluate the safety assessment of novel combinatorial Nanoparticle formulation.
Methods: Chitosan nanoparticles were prepared by the ionic gelation method with slight modification. Drug-drug interaction was evaluated by Fourier Transform Infra-Red Spectroscopy. Size, Polydispersity Index, Zeta potential, Transmission Electron Microscopy Characterizations were performed as per standard procedures. Acute and subacute toxicity assessments were done by the standard protocol of OECD guideline number 425 and 407, respectively.
Results: Size and zeta-potential were found to be 186.7 nm and-12.0mV, respectively. TEM analysis showed uniform, smooth, and spherical-sized particles. FTIR analysis of carvedilol, sericin, and physical mixture showed no interaction between them. The safety evaluation of prepared nanoparticle which was found to be safe at a dose of up to 1000 mg/kg body weight in single-dose acute toxicity and multiple-dose subacute toxicity study. Biochemical estimations were statistically evaluated and no significant differences were found that the mean P-value is greater than 0.05 and Histopathological examination has shown no marked disparity when compared to the normal control group.
Conclusion: It can be concluded that the prepared Nanoparticles are safe in rodents and can be preceded for further evaluation for its preclinical cardioprotective potential.
Downloads
References
Mamaeva V, Sahlgren C, Linden M. Mesoporous silica nanoparticles in medicine-recent advances. Adv Drug Deliv Rev. 2013;65(5):689-702. doi: 10.1016/j.addr.2012.07.018, PMID 22921598.
Nasiruddin M, Neyaz MK, Das S. Nanotechnology-based approach in tuberculosis treatment. Tuberc Res Treat. 2017;2017:4920209. doi: 10.1155/2017/4920209, PMID 28210505.
Mehra R, Aanchal KS, Kalsi SP, Gautam SP. Hypertension in relation to immune system and way of life along with treatment. Int J Curr Pharm Sci. 2021;13(6):1-10. doi: 10.22159/ijcpr.2021v13i6.1907.
Anuradha Vp, CM, Sruthy SA. Drug utilization pattern of antihypertensive medications in a tertiary care hospital, South India. Asian J Pharm Clin Res 2022;15(1):115-8. doi: 10.22159/ajpcr.2022.v15i1.43438.
Sharma M, Sharma R, Jain DK. Nanotechnology-based approaches for enhancing oral bioavailability of poorly water-soluble antihypertensive drugs. Scientifica. 2016;2016:8525679. doi: 10.1155/2016/8525679, PMID 27239378.
Ladage D, Schwinger RH, Brixius K. Cardio‐selective beta‐blocker: pharmacological evidence and their influence on exercise capacity. Cardiovasc Ther. 2013;31(2):76-83. doi: 10.1111/j.1755-5922.2011.00306.x. PMID 22279967.
Mahmood T, Siddiqui H, Dixit R, Bagga P, Hussain S. Protective effect of Bombyx mori L cocoon (Abresham) and its formulations against isoproterenol-induced cardiac damage. Trop J Pharm Res 2015;14(1):63-72. doi: 10.4314/tjpr.v14i1.10.
Younes I, Rinaudo M. Chitin and chitosan preparation from marine sources. Structure, properties and applications. Mar Drugs. 2015;13(3):1133-74. doi: 10.3390/md13031133, PMID 25738328.
Czoty PW, Stoops WW, Rush CR. Evaluation of the ”pipeline” for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research. Pharmacol Rev. 2016;68(3):533-62. doi: 10.1124/ pr.115.011668, PMID 27255266.
Bound JP, Voulvoulis N. Pharmaceuticals in the aquatic environment- a comparison of risk assessment strategies. Chemosphere. 2004;56(11):1143-55. doi: 10.1016/j.chemosphere.2004.05.010, PMID 15276728.
Vengaimaran M, Dhamodharan K, Sankaran M. Therapeutic profiling of nano encapsulated diosgenin via attenuating hormonal status, cell proliferation, inflammatory responses, and apoptosis in an animal model of mammary oncogenesis. Int J Appl Pharm. 2021;13:126-32. doi: 10.22159/ ijap.2021v13i6.42777.
Otsuka Y, Kuwashima W, Tanaka Y, Yamaki Y, Shimada Y, Goto S. Effects of heat treatment on indomethacin-cimetidine mixture; investigation of drug-drug interaction using singular value decomposition in ftir spectroscopy. J Pharm Sci. 2021;110(3):1142-7. doi: 10.1016/j.xphs.2020.09.049, PMID 33035536.
Sun L, Wang Y, Jiang T, Zheng X, Zhang J, Sun J, Sun C, Wang S. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol. ACS Appl Mater Interfaces. 2013;5(1):103-13. doi: 10.1021/am302246s, PMID 23237208.
Mohamed NR, Badr TM, Elnagar MR. Efficiency of curcumin and chitosan nanoparticles against toxicity of potassium dichromate in male mice. Int J Pharm Pharm Sci. 2021;13:14-23. doi: 10.22159/ijpps.2021v13i2.40224.
OECD 425. Test No. 425: acute oral toxicity: up-and-down procedure. OECD; 2018. https://www.oecdilibrary.org/ docserver/9789264071049en.pdf?expires=1627383728andid=idandaccname=guestandchecksum=A934009F428948F8D282DB2C6C141E37.
Saleem U, Amin S, Ahmad B, Azeem H, Anwar F, Mary S. Acute oral toxicity evaluation of aqueous ethanolic extract of Saccharum munja Roxb. roots in albino mice as per OECD 425 TG. Toxicol Rep. 2017;4:580-5. doi: 10.1016/ j.toxrep.2017.10.005. PMID 29152463.
OECD guidelines for the testing of chemicals: repeated dose 28-day oral toxicity study in rodents. Available from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg407-2008.pdf
Porwal M, Khan NA, Maheshwari KK. Evaluation of acute and subacute oral toxicity induced by ethanolic extract of Marsdenia tenacissima leaves in experimental rats. Sci Pharm. 2017;85(3):29. doi: 10.3390/scipharm85030029, PMID 28825665.
Kant V, Verma PK, Pankaj N, Kumar J, Raina R, Srivastava A. Haematological profile of subacute oral toxicity of fluoride and ameliorative efficacy of aluminium sulphate in goats. Toxicol Int. 2009;16(1):31.
Saha P, Mazumder UK, Haldar PK, Islam A, Kumar RS. Evaluation of acute and subchronic toxicity of lagenaria siceraria aerial parts. Int J Pharm Sci Res. 2011;2(6):1507.
Mythilypriya R, Shanthi P, Sachdanandam P. Oral acute and subacute toxicity studies with Kalpaamruthaa, a modified indigenous preparation, on rats. J Health Sci. 2007;53(4):351-8. doi: 10.1248/jhs.53.351.
Pittler MH, Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther. 2003;18(5):451-71. doi: 10.1046/j.1365-2036.2003. 01689.x. PMID 12950418.
Rifai N, Russell Warnick G, Dominiczak MH. eds. Handbook of lipoprotein testing. Amer. Assoc. Clin Chem; 2000.
Singh A, Kumar R, Kannaujia SK, Singh NP. Hematobiocemical and histopathological studies on the effects of raj Nirwan Bati (A novel Allovedic drug) in wistar rats. Int J Pharm Pharm Sci. 2022;14:21-30. doi: 10.22159/ijpps.2022v14i2.42935.
Published
How to Cite
Issue
Section
Copyright (c) 2022 MOHAMMAD SHARIQ, TARIQUE MAHMOOD ANSARI, POONAM KUSHWAHA, SABA PARVEEN, ARSHIYA SHAMIM, FAROGH AHSAN, MOHAMMAD TAHA KAZMI
This work is licensed under a Creative Commons Attribution 4.0 International License.
